We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+0.63%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.11B
AUM Growth
+$207M
Cap. Flow
+$183M
Cap. Flow %
2.99%
Top 10 Hldgs %
49.09%
Holding
188
New
51
Increased
37
Reduced
33
Closed
43

Top Sells

Rank Stock Value
1
FIVE icon
Five Below
FIVE
+$67.4M
2
PTCT icon
PTC Therapeutics
PTCT
+$64.3M
3
ENTA icon
Enanta Pharmaceuticals
ENTA
+$61.2M
4
BURL icon
Burlington
BURL
+$60.4M
5
ROST icon
Ross Stores
ROST
+$42.3M

Sector Composition

Rank Sector Weight
1 Healthcare 42.67%
2 Consumer Discretionary 7.86%
3 Consumer Staples 7.27%
4 Technology 5.96%
5 Communication Services 1.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPLK
101
DELISTED
Splunk Inc
SPLK
$6.94M 0.11%
+60,000
New +$8.38M
PHXM
102
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
$6.43M 0.11%
+273,757
New +$9.23M
HNST icon
103
The Honest Company
HNST
$432M
$5.86M 0.1%
724,000
+32,000
+5% +$281K
MNST icon
104
Monster Beverage
MNST
$92.5B
$5.76M 0.09%
+120,000
New +$5.33M
SLAI
105
DELISTED
SOLAI Ltd ADS
SLAI
$5.4M 0.09%
12,571
SIEN
106
DELISTED
Sientra, Inc.
SIEN
$4.98M 0.08%
135,600
+2,100
+2% +$102K
SWAG icon
107
Stran & Co
SWAG
$35.2M
$4.87M 0.08%
+804,829
New +$4.07M
CRXT
108
DELISTED
Clarus Therapeutics Holdings, Inc. Common Stock
CRXT
$4.69M 0.08%
+1,929,876
New +$8.38M
TLPH icon
109
Talphera
TLPH
$70.1M
$4.69M 0.08%
+418,250
New +$6.36M
ASMB icon
110
Assembly Biosciences
ASMB
$525M
$4.66M 0.08%
166,667
-17,333
-9% -$568K
TELA icon
111
TELA Bio
TELA
$40.6M
$4.45M 0.07%
348,000
MARK
112
DELISTED
Remark Holdings, Inc.
MARK
$4.2M 0.07%
423,729
ACCO icon
113
Acco Brands
ACCO
$400M
$4.13M 0.07%
500,000
-356,000
-42% -$3.07M
VSTM icon
114
Verastem
VSTM
$515M
$4.1M 0.07%
166,667
XTIA icon
115
XTI Aerospace
XTIA
$58.1M
$4.06M 0.07%
4
ADXN
116
Addex Therapeutics
ADXN
$7.2M
$3.87M 0.06%
+30,762
New +$4.64M
SCPS
117
DELISTED
Scopus BioPharma Inc. Common Stock
SCPS
$3.43M 0.06%
+2,100,000
New +$6.37M
PIXY
118
DELISTED
ShiftPixy, Inc. Common Stock
PIXY
$3.33M 0.05%
79
EFOI icon
119
Energy Focus
EFOI
$19.6M
$2.67M 0.04%
+89,286
New +$1.9M
OG
120
DELISTED
Onion Global Limited American Depositary Shares (each ten (10) ADSs representing one (1) Class A Ordinary Share)
OG
$2.38M 0.04%
+943,390
New +$5.47M
TENX icon
121
Tenax Therapeutics
TENX
$501M
$2.1M 0.03%
1,262
RVPH
122
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
$2.04M 0.03%
35,379
+3,844
+12% +$274K
BCTXW
123
DELISTED
BriaCell Therapeutics Corp Warrant
BCTXW
$1.76M 0.03%
375,000
XCUR icon
124
Exicure
XCUR
$9.43M
$1.74M 0.03%
+57,351
New +$6.65M
HSTO
125
DELISTED
Histogen Inc. Common Stock
HSTO
$1.64M 0.03%
+247,059
New +$2.83M

Similar funds

Armistice Capital's Q4 2021 Portfolio in Review

As of Q4 2021, Armistice Capital held 188 positions worth $6.11B, up 3.5% from $5.9B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Armistice Capital's Q4 2021 filing shows 51 new, 37 increased, 33 reduced and 43 closed positions. Its largest new stake was AutoZone: 38,024 shares worth $79.7M. The largest sale was Five Below, an estimated $67.4M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 45% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

  • Armistice Capital's largest Q4 2021 buy was AutoZone: 38,024 shares worth $79.7M.
  • Armistice Capital added most to Jazz Pharmaceuticals in Q4 2021, an estimated $72.8M increase.
  • Armistice Capital's biggest Q4 2021 reduction was PTC Therapeutics, cutting an estimated $64.3M.
  • Armistice Capital fully exited Five Below in Q4 2021, selling an estimated $67.4M.
  • Armistice Capital's ten largest holdings make up 49% of its $6.11B portfolio in Q4 2021.
  • Armistice Capital opened 51 new positions and closed 43 in Q4 2021.
  • Armistice Capital's portfolio value rose 3.5% quarter-over-quarter to $6.11B.

Based on Armistice Capital's 13F filing for Q4 2021, filed 14 Feb 2022.